Keyphrases
Neuroinflammation
100%
Angiotensin Receptor Blockers
100%
Cannabidiol
100%
Nitric Oxide Release
100%
Telmisartan
46%
Lipopolysaccharide-induced
26%
Monomethyl Fumarate
26%
Angiotensin II Type 1 Receptor (AT1R)
20%
Synergistic Inhibition
13%
Lipopolysaccharide
13%
Additive Effect
13%
Beta-blockers
13%
Losartan
13%
Statistical Significance
6%
Cognitive Decline
6%
Interleukin-17 (IL-17)
6%
Interferon-α (IFN-α)
6%
NO Production
6%
Anti-inflammatory Effect
6%
Nitric Oxide Production
6%
Cannabis
6%
Anti-inflammatory Agents
6%
Combination Therapy
6%
Glial Cells
6%
Neuroprotective
6%
Angiotensin II (Ang II)
6%
Inhibition Rate
6%
New Combination
6%
Phytocannabinoids
6%
Anti-neuroinflammation
6%
Glial Inflammation
6%
Dimethyl Fumarate
6%
NO Synthesis
6%
Pharmacology, Toxicology and Pharmaceutical Science
Nitric Oxide
100%
Angiotensin Receptor Antagonist
100%
Nervous System Inflammation
100%
Cannabidiol
100%
Telmisartan
46%
Lipopolysaccharide
40%
Fumaric Acid Methyl Ester
26%
Tumor Necrosis Factor
13%
Angiotensin 1 Receptor Antagonist
13%
Losartan
13%
Combination Therapy
6%
Interleukin 17
6%
Inflammation
6%
Interferon
6%
Antiinflammatory Activity
6%
Epileptic Absence
6%
Cannabis
6%
Antiinflammatory Agent
6%
Neuroprotective Agent
6%
Angiotensin II
6%
Angiotensin 1 Receptor
6%
Fumaric Acid Dimethyl Ester
6%
Neuroscience
Nitric Oxide
100%
Angiotensin Receptor
100%
Cannabidiol
100%
Telmisartan
46%
Lipopolysaccharide
40%
Angiotensin II Receptor Type 1
20%
Losartan
13%
Anti-Inflammatory
6%
Interferon
6%
Epileptic Absence
6%
Anti-Inflammatory Agent
6%
Interleukin 17
6%
Neuroprotective Agent
6%
Glial Cells
6%
Angiotensin II
6%
Cannabis
6%